Mobile App

Google Play Apple Store
Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care
AMA/ABS/ANCC/ACPE- Enduring Activity
Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes.

These Mini-Modules are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules.
Review the activity and claim AMA, ABS, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.








 
Alice Gottlieb, MD, PhD Alice Gottlieb, MD, PhD
Clinical Professor, Icahn School of Medicine at Mount Sinai

Mark Lebwohl, MD Mark Lebwohl, MD
Dean for Clinical Therapeutics
Icahn School of Medicine at Mount Sinai
Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology
Mount Sinai Health System

Philip Mease, MD Philip Mease, MD
Director, Rheumatology Research, Providence Swedish Medical
Clinical Professor, University of Washington School of Medicine

20
Supported by independent educational grants from
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC and Eli Lilly and Company

Launch Date: March 25, 2025
Release Date: March 25, 2025
Expiration Date: February 28, 2026

Mini Module
7899
Conversations_PsoriasisPsoriaticArthritis_1730x162.gif
True
Dermatology

CookieConsent

Change Settings